DongKoo Bio & Pharma Co., Ltd.

₩3,330As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:006620Healthcare
Country South Korea
PE (Fwd) •••
TSR 9Y CAGR (13.31%)
Div yield 3.60%
ROE 25.82%
Pharmaceutical Preparations
Beta (5Y) 0.35
PE TTM 2.796
TSR TTM (36.59%)
Mkt cap ₩90.05B
ROIC 0.11%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,343
0.40%
(95.70%)
Hold 0|9|12|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
68.36
71.54
68.80
76.53
11.72%
7.21%
(2.00%)
10.50%
Revenue₩B
5.698
5.986
5.996
6.349
8.58%
15.82%
11.65%
13.93%
Peers (US$66.39M)
Cap (US$)
PE
68.91M
7.871x
Capital
TTM
5Y
10Y
Leveragex
0.388
0.609
0.483
EBIT/Intx
2.159
0.240
0.238
Own earn%
69.89
(37.73)
(44.59)
Sh yield%
16.39
34.95
33.28
Owners
Insiders/Inst%
5.00
45.69
Short interest%
3.13
SBC / revenue%
5.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
4–10
$1 testx
—
Incr. ROIC%
3